Literature DB >> 2253536

Effects of cisapride on gastrointestinal transit in healthy humans.

J L Madsen1.   

Abstract

It was the aim of this study to assess the effects of cisapride on gastrointestinal transit of solids in healthy humans. Twelve men received cisapride 10 mg or placebo orally four times a day in random, double-blind, crossover fashion. Transit measurements were performed with a new gamma camera technique. Cisapride reduced mean gastric emptying time of 99mTc-labeled cellulose fiber [0.77 (0.69-1.12) hr [median (range)] vs 0.98 (0.63-1.95) hr; P less than 0.05] and 1- to 2-mm 111In-labeled plastic particles [1.08 (0.50-1.42) hr vs 1.69 (0.59-3.03) hr; P less than 0.01]. Cisapride also decreased mean small intestinal transit time of cellulose fiber [2.11 (0.80-5.08) hr vs 2.82 (0.78-7.12) hr; P less than 0.05] and plastic particles [2.06 (1.13-5.13) hr vs 2.64 (1.18-7.04) hr; P less than 0.05]. However, cisapride increased mean large intestinal transit time of plastic particles [31 (13-75) hr vs 23 (12-36) hr; P less than 0.05]. In conclusion, oral cisapride 10 mg four times a day accelerates gastric emptying and small intestinal transit whereas this dose of cisapride seems to delay large intestinal transit of solids in healthy humans.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253536     DOI: 10.1007/bf01540568

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  Cisapride stimulates propulsive motility patterns in human jejunum.

Authors:  G Coremans; J Janssens; G Vantrappen; S Chaussade; P Ceccatelli
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

2.  Treatment of chronic constipation with cisapride and placebo.

Authors:  S A Müller-Lissner
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

3.  Cisapride accelerates colonic transit in constipated patients with colonic inertia.

Authors:  B Krevsky; A H Maurer; L S Malmud; R S Fisher
Journal:  Am J Gastroenterol       Date:  1989-08       Impact factor: 10.864

4.  Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride.

Authors:  M Camilleri; M L Brown; J R Malagelada
Journal:  Gastroenterology       Date:  1986-09       Impact factor: 22.682

5.  Effect of cisapride on the gastrointestinal transit of a solid meal in normal human subjects.

Authors:  C A Edwards; S Holden; C Brown; N W Read
Journal:  Gut       Date:  1987-01       Impact factor: 23.059

6.  Colon motility and colo-anal reflexes in chronic idiopathic constipation. Effects of a novel enterokinetic agent cisapride.

Authors:  G Reboa; G Arnulfo; M Frascio; C Di Somma; G Pitto; E Berti-Riboli
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Effects of cisapride on postcibal jejunal motor activity.

Authors:  G Stacher; G Gaupmann; H Steinringer; C Schneider; G Stacher-Janotta; G Steiner-Mittelbach; T A Abatzi
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

8.  Effects of cisapride on jejunal motor activity in fasting healthy humans.

Authors:  G Stacher; H Steinringer; C Schneider; S Winklehner; G Mittelbach; G Gaupmann
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

9.  The effect of cisapride and metoclopramide on human digestive and interdigestive antroduodenal motility.

Authors:  G Lux; M Katschinski; S Ludwig; P Lederer; A Ellermann; W Domschke
Journal:  Scand J Gastroenterol       Date:  1994-12       Impact factor: 2.423

10.  The effect of oral cisapride on colonic transit.

Authors:  B Krevsky; L S Malmud; A H Maurer; M B Somers; J A Siegel; R S Fisher
Journal:  Aliment Pharmacol Ther       Date:  1987-08       Impact factor: 8.171

View more
  9 in total

1.  Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate.

Authors:  J A Zix; H F Geerdes-Fenge; M Rau; J Vöckler; K Borner; P Koeppe; H Lode
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Impact of gastric emptying on the pharmacokinetics of ethanol as influenced by cisapride.

Authors:  S Kechagias; K A Jönsson; A W Jones
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

3.  Single oral dose of cisapride accelerates gastric antral emptying in healthy humans: an ultrasonographic study.

Authors:  T Takeda; H Konomi; G Naritomi; J Yoshida; H Matsunaga; K Akazawa; M Tanaka
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

4.  Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans.

Authors:  E P Bouras; M Camilleri; D D Burton; S McKinzie
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

5.  Randomised controlled trial of cisapride in preterm infants.

Authors:  R J McClure; J H Kristensen; A Grauaug
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

Review 6.  Functional dyspepsia. Current treatment recommendations.

Authors:  Gerald Holtmann; Nicholas J Talley
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

7.  Gastrointestinal transit times of radiolabeled meal in progressive systemic sclerosis.

Authors:  J L Madsen; L Hendel
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

Review 8.  Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

Review 9.  Gastrointestinal Involvement in Systemic Sclerosis: An Update.

Authors:  John B Miller; Nisarg Gandhi; John Clarke; Zsuzsanna McMahan
Journal:  J Clin Rheumatol       Date:  2018-09       Impact factor: 3.517

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.